Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 1,018 shares at $47.27 ($48K) on 2017-05-24, disclosed to the SEC on 2017-05-25.
Scheduled sale ($48k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.27 | 509 | $24K | 50.2% |
| 2 | $46.92 | 509 | $24K | 49.8% |
| Total | $47.10 avg | 1,018 | $48K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |